Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Barbeau Pharma prepares and tests novel dopamine D2 receptor antagonists

May 16, 2006

Gedeon Richter signs new agreement for antipsychotic RGH-188

May 16, 2006

Lexicon Genetics receives grant for target identification in spinal muscular atrophy

May 16, 2006

The alpha2delta1 subunit of the VGCC: a drug target for neuropathic pain / News in Context

May 16, 2006

Eugenol: a phytochemical with in vivo antihyperalgesic efficacy

May 16, 2006

Novel agents for treating neurological disorders disclosed in recent patent literature

May 15, 2006

Recent patents report novel analgesic agents

May 15, 2006

NG2-73 significantly reduces time to onset of persistent sleep

May 15, 2006

PharmaFrontiers presents data on T-cell and stem cell technology

May 15, 2006

DepoMed finalizes phase III protocol for Gabapentin GR study

May 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...